Clinical Trial Update: Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms [Phase 2]

View source ↗

Summary

Phase 2 study validating patient-reported outcome measures for assessing gastroesophageal reflux disease symptoms. The study, sponsored by AstraZeneca, evaluate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD, Acid Reflux Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-06-20